Showing results (51-60 of 91) with videos related to
Sort By:
Pageof 10
Cancer Chemotherapy and Pharmacology|August 15, 2014
Pharmacokinetics and pharmacogenomics of daunorubicin in children: a report from the Children's Oncology GroupPatrick Thompson, Heather E Wheeler, Shannon M Delaney, et al.Cancer|June 4, 2014
The Children's Oncology Group Childhood Cancer Research Network (CCRN): case catchment in the United StatesJessica R B Musselman, Logan G Spector, Mark D Krailo, et al.Cancer|March 6, 2007
Upfront window trial of topotecan in previously untreated children and adolescents with poor prognosis metastatic osteosarcoma: children's Cancer Group (CCG) 7943Nita L Seibel, Mark Krailo, Zhengjia Chen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
Phase I study of ch14.18 with granulocyte-macrophage colony-stimulating factor and interleukin-2 in children with neuroblastoma after autologous bone marrow transplantation or stem-cell rescue: a report from the Children's Oncology GroupAndrew L Gilman, M Fevzi Ozkaynak, Katherine K Matthay, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2019
Challenges with Novel Clinical Trial Designs: Master ProtocolsMichael Cecchini, Eric H Rubin, Gideon M Blumenthal, et al.Blood|June 7, 2013
Erwinia asparaginase achieves therapeutic activity after pegaspargase allergy: a report from the Children's Oncology GroupWanda L Salzer, Barbara Asselin, Jeffrey G Supko, et al.Blood|October 26, 2007
Phase 1 trial and pharmacokinetic study of arsenic trioxide in children and adolescents with refractory or relapsed acute leukemia, including acute promyelocytic leukemia or lymphomaElizabeth Fox, Bassem I Razzouk, Brigitte C Widemann, et al.Cancer|August 21, 2007
Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children's Oncology GroupH Stacy Nicholson, Cynthia S Kretschmar, Mark Krailo, et al.British Journal of Haematology|December 21, 2004
Phase I/II dose escalation study of recombinant human interleukin-11 following ifosfamide, carboplatin and etoposide in children, adolescents and young adults with solid tumours or lymphoma: a clinical, haematological and biological studyMitchell S Cairo, Virginia Davenport, Olga Bessmertny, et al.Pediatric Blood & Cancer|July 21, 2006
Substitution of oral and intravenous thioguanine for mercaptopurine in a treatment regimen for children with standard risk acute lymphoblastic leukemia: a collaborative Children's Oncology Group/National Cancer Institute pilot trial (CCG-1942)Shana S Jacobs, Linda C Stork, Bruce C Bostrom, et al.Pageof 10